Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Dis Colon Rectum ; 42(1): 50-5, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10211520

ABSTRACT

PURPOSE: This retrospective study was undertaken to evaluate immunohistochemically the expression of CD44 standard protein and CD44v5 and CD44v6 isoforms in colorectal adenomas and early invasive cancers developing within adenomas as possible markers characterizing colorectal polyps with a more aggressive biologic potential. METHODS: Archival tissues of 81 consecutive locally resected colorectal polyps, comprising 57 colorectal adenomas and 24 carcinomas-in-adenomas, were stained immunohistochemically with the use of commercially available mouse monoclonal antibodies: SFF-2 for CD44 standard protein, VFF-8 for CD44v5, and VFF-7 for CD44v6. RESULTS: Sixty-three percent of the colorectal polyps were positive for CD44 standard protein, 59 percent were positive for CD44v5, and 27 percent were positive for CD44v6. Ninety-three percent of the low-grade adenomas were CD44 standard protein-positive, in contrast to 50 percent of the high-grade adenomas and only 42 percent of the carcinomas-in-adenomas (Kendall's Tau = -0.42; P < 0.0001). CD44v6 expression was more frequently found in early invasive cancers (54 percent) than in high-grade adenomas (25 percent) and low-grade adenomas (7 percent). This difference also was statistically significant (Kendall's Tau-b = 0.39; P = 0.00003). Surprisingly, a downregulation of CD44 standard protein expression was observed in the adenoma tissue adjacent to carcinomas (62 percent) and areas with high-grade atypia (71 percent), compared with low-grade adenomas (93 percent; Kendall's Tau-b = -0.28; P = 0.004). CONCLUSIONS: Our data suggest that CD44 standard protein and CD44 isoform v6 expression differs considerably in benign and malignant colorectal polyps. Clinical studies with larger patient groups could clarify the prognostic potential of CD44 further.


Subject(s)
Adenoma/chemistry , Colonic Polyps/chemistry , Colorectal Neoplasms/chemistry , Hyaluronan Receptors/analysis , Adenoma/pathology , Animals , Biomarkers, Tumor/analysis , Carcinoma/chemistry , Carcinoma/pathology , Colonic Polyps/pathology , Colorectal Neoplasms/pathology , Humans , Immunohistochemistry , Mice , Neoplasm Staging , Retrospective Studies
2.
Int J Dermatol ; 38(2): 149-53, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10192170

ABSTRACT

BACKGROUND: Atrophic acne scars are a frequent problem after acne. Hitherto, mainly invasive treatment measures were possible. In a recent paper, we demonstrated the positive effects of iontophoresis with 0.025% tretinoin gel vs. estriol 0.03%. OBJECTIVE: In this further study, the recording of the clinical effects of iontophoresis with 0.025% tretinoin gel in atrophic acne scars was supplemented by immunohistochemistry investigations of collagen I and III, proliferation markers, and the estimation of epidermal thickness. METHODS: The treatment was performed twice weekly in 32 volunteer patients for a period of 3 months by application of the substance under a constant direct current of 3 mA for 20 min. Skin biopsies prior to and at the end of treatment were performed in 32 voluntary patients in order to investigate collagen I/III and proliferation markers by immunohistochemistry methods. RESULTS: Clinically, at the end of treatment, in 94% of patients a significant decrease in the scar depth was observed. Neither epidermal thickness nor proliferation markers revealed a significant increase at the end of treatment. Furthermore, collagen I and collagen III showed no common trend, as expressed statistically by a lack of significance. In some cases, increases in collagen III became evident at the end of treatment. CONCLUSIONS: Tretinoin-iontophoresis is an effective, noninvasive treatment of atrophic acne scars without causing disturbing side-effects.


Subject(s)
Acne Vulgaris/drug therapy , Cicatrix/drug therapy , Iontophoresis , Keratolytic Agents/therapeutic use , Tretinoin/therapeutic use , Acne Vulgaris/metabolism , Acne Vulgaris/pathology , Administration, Cutaneous , Adolescent , Adult , Atrophy , Cicatrix/metabolism , Cicatrix/pathology , Collagen/analysis , Female , Humans , Immunohistochemistry , Keratolytic Agents/administration & dosage , Ki-67 Antigen/analysis , Male , Middle Aged , Skin/chemistry , Skin/drug effects , Skin/pathology , Treatment Outcome , Tretinoin/administration & dosage
3.
Eur J Cancer ; 33(1): 39-44, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9071897

ABSTRACT

p53 and c-erbB-2 expression, and their correlation with cell proliferation and steroid hormone receptors, were investigated in 121 carcinomas, 23 lobular in situ carcinomas (LCIS), 74 intraductal carcinomas (DCIS) and 24 minimal invasive carcinomas. DCIS were classified according to the EORTC classification. All markers were measured immunohistochemically on paraffin sections. None of the LCIS, 9 DCIS and 9 minimal invasive cancers showed nuclear positivity for p53. A strong association between histological type and p53 expression was found. Proliferation rates correlated with p53 expression. c-erbB-2 positivity was found in 1 LCIS, 27 DCIS and 12 minimal invasive cancers. There was a significant correlation between p53 expression and c-erbB-2. Both parameters were associated with high proliferation rate and negativity for steroid hormone receptor status. Nuclear pleomorphism could become a comparable prognostic marker in DCIS as it is for infiltrating carcinomas.


Subject(s)
Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Carcinoma in Situ/metabolism , Carcinoma, Ductal, Breast/metabolism , Carcinoma, Lobular/metabolism , Tumor Suppressor Protein p53/metabolism , Breast Neoplasms/pathology , Carcinoma in Situ/pathology , Carcinoma, Ductal, Breast/pathology , Carcinoma, Lobular/pathology , Cell Division , Female , Humans , Neoplasm Proteins/metabolism , Prognosis , Receptor, ErbB-2/metabolism , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism
4.
Breast Cancer Res Treat ; 32(2): 165-75, 1994.
Article in English | MEDLINE | ID: mdl-7865846

ABSTRACT

In situ determination of proliferative activity was performed on 184 consecutive primary invasive breast cancers. Methods used were monoclonal antibody Ki-67 in immunohistochemistry and thymidine labeling index. Tumor proliferation correlated between both methods (p = 0.0001). For thymidine labeling index and Ki-67, respectively, significant correlations existed with histologic tumour grade and steroid hormone receptors (Tumor grade: TLI p = 0.0001; Ki-67 p = 0.0001. ER-ICA: TLI = 0.0001; Ki-67 p = 0.014. PgR-ICA: TLI p = 0.0001; Ki-67 p = 0.0008). For thymidine labeling index a significant correlation was demonstrated for overall survival (p = 0.001) and recurrence free survival (p = 0.01). No statistical significance was observed for clinical outcome and Ki-67 (overall survival p = 0.18; recurrence free survival p = 0.1). None of the factors, TLI or Ki-67, was an independent prognostic factor as demonstrated by multivariate analysis.


Subject(s)
Breast Neoplasms/pathology , DNA Replication , DNA, Neoplasm/biosynthesis , Neoplasm Proteins/analysis , Nuclear Proteins/analysis , Breast Neoplasms/mortality , Cell Division , Cohort Studies , Humans , Ki-67 Antigen , Prognosis , Proportional Hazards Models , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Risk , Survival Analysis
5.
Ment Retard ; 31(6): 396-402, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8152385

ABSTRACT

Although full participation in community life should be available to all individuals with mental retardation, some may prefer segregated participation in selected activities. Freedom of choice is particularly important in leisure activities. In this exploratory study we investigated whether individuals with Down syndrome would prefer to participate in bowling with other people who had Down syndrome or with people who had no apparent mental retardation. Structured interviews, in conjunction with videotapes of two bowling groups, revealed that 15 of the 21 adult subjects preferred to bowl with others who had Down syndrome. If either segregated or integrated activities are denied to adults with mental retardation, their opportunities for experiencing the benefits of freely chosen leisure participation are also systematically denied.


Subject(s)
Choice Behavior , Down Syndrome/psychology , Leisure Activities , Peer Group , Adult , Female , Humans , Interpersonal Relations , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...